Loading News...
Back to Dashboard

Heartflow, Inc. (HTFL)

Real-time intraday values

Market Overview

From:
To:
HTFL Intraday
No data available
SymbolHTFL
IPO DateAug 11, 2025
CEOMr. John C.M. Farquhar
Full Time Employees843
SectorHealthcare
IndustryHealth Information Services
CountryUnited States
ExchangeNasdaqGS
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.
Performance
PeriodReturn %Value Change
1 Day
+4.74%
+2.11 US$
5 Days
-3.54%
-1.71 US$
1 Month
-16.26%
-9.07 US$
6 Months
+58.51%
+17.26 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of HTFL...

Key Statistics
Market Cap
4.10B
P/E Ratio
69.69
Div Yield
0.00%
52W High
$60.66
52W Low
$20.13

Analyst Consensus

ConsensusStrong Buy
Bullish888.9%
Neutral111.1%
Bearish00.0%

52W Analyst Price Targets

Min Target
$59.00
Max Target
$70.00
Current$46.74
Avg Target$65.00

Analyst Recommendations

Target Price:$65.00($59.00 - $70.00)
FirmRatingTarget PriceUpside PotentialDate
Piper SandlerOverweight$64.00+36.91%10/20/2026
Canaccord GenuityBuy$56.00+19.80%9/22/2026
UBSNeutral$55.00+17.66%9/9/2026
Canaccord GenuityBuy$45.00-3.73%8/14/2026
Morgan StanleyEqual-Weight$40.00-14.43%8/14/2026
Piper SandlerOverweight$45.00-3.73%8/14/2026
JP MorganOverweight$45.00-3.73%8/14/2026
Wells FargoOverweight$39.00-16.57%8/14/2026
StifelBuy$45.00-3.73%8/14/2026
BairdOutperform$34.00-27.26%7/31/2026

Looking for more stocks? Explore them in the screener

Community Thoughts

Share your analysis and sentiment on HTFL

Join the community to share your analysis